Role of sialoglycan binding in the pathogenesis of streptococcal endocarditis
唾液酸聚糖结合在链球菌心内膜炎发病机制中的作用
基本信息
- 批准号:10714047
- 负责人:
- 金额:$ 80.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-17 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAffinityAnimal ModelAntigensAttenuatedBacteriaBacterial AdhesinsBindingBinding ProteinsBiomechanicsBiomedical EngineeringBloodBlood CellsBlood CirculationBlood PlateletsCardiacCell WallCellsCirculationCoagulation ProcessCollagenComplexDiseaseDisease ProgressionDisease modelEndocarditisEndocardiumEndotheliumEventFamilyFibrinFlow CytometryGenesGlycoproteinsHeartHeart ValvesHumanImmobilizationIn VitroInfectionInfective endocarditisLesionLifeLigandsLinkMeasuresMediatingMicrobial BiofilmsMicrofluidicsModelingMutagenesisOrganismPathogenesisPathogenicityPhysiologicalPlasmaPlasma ProteinsPlatelet ActivationPolysaccharidesProductionProteinsRattusResearchRoleSerineSiteSite-Directed MutagenesisStreamStreptococcusStreptococcus gordoniiStreptococcus sanguisStructureSurfaceThrombosisThrombusTrisaccharidesVariantVascular Endothelial CellVirulenceVirulentWorkadhesion receptorantigen bindingenhancing factorhealingheart damagehemodynamicsin vivoinsightlactosaminemechanotransductionmicroorganism interactionmutantnew therapeutic targetnovelnovel therapeuticsoral streptococcipathogenplatelet functionreceptorrecruitshear stresssialic acid binding Ig-like lectinsingle-cell RNA sequencingsugarvon Willebrand Factor
项目摘要
PROJECT SUMMARY
The oral streptococci are a major cause of infective endocarditis (IE). Several of these species express Siglec-
like, serine-rich repeat (SRR) adhesins that bind a variety of O-linked sialoglycans on human glycoproteins and
cells. Expression of the SRR adhesin GspB of Streptococcus gordonii M99 results in increased virulence in
animal models of IE. This enhanced pathogenicity is thought to be due the interaction of GspB with the
trisaccharide sialyl-T antigen (sTa, a core 1 sialoglycan) on the platelet receptor GPIb, leading to increased
attachment of bacteria in the blood stream to cardiac valve surfaces and vegetation formation. Isogenic
mutants of M99 expressing GspB variants that preferentially bind core 2 sialoglycans,(e.g., sialyl-lactosamine)
are less virulent, as compared with the WT strain. These findings indicate that differences in the type of
sialoglycan bound ("selectivity") affect the ability of organisms to both initiate and propagate endocardial
infection, with some interactions enhancing pathogenesis, while other interactions reducing disease. We
hypothesize that in vivo, the binding of streptococci in the bloodstream to sTa on platelets or cardiac surfaces
helps initiate infection, and that this binding is enhanced by hemodynamic effects created by high shear flow.
In contrast, binding to core 2 sialoglycans on blood cells may lead to increased bacterial clearance, thereby
attenuating virulence. Subsequent interactions of bacteria on valves with core 1 versus core 2 sialoglycans
may affect disease progression via different effects on platelet activation, clotting, or endothelial healing.
To further address the roles of sialoglycan binding selectivity in the pathogenesis of IE, we will compare by flow
the above isogenic strains for their binding to platelets, RBCs and WBCs in vitro. We will also examine whether
these strains bind platelets that differ in GPIb sialoglycan content, and whether binding to sTa versus core 2
structures affects platelet activation. In addition, we will assess how selectivity impacts the attachment of
bacteria to damaged cardiac surfaces, as modeled by microfluidic chambers lined with immobilized platelets,
von Willebrand Factor, collagen or activated human vascular endothelial cells, and the effect of hemodynamic
forces on binding. We will also explore the impact of selectivity on vegetation formation by assessing strain
differences in triggering platelet contractility and effects on platelet-dependent endothelial healing. We will also
compare vegetations produced in vivo by these strains for key features linked to virulence, including co-
localization with platelet and biofilm production.
These studies will provide novel insights as to how sialoglycan selectivity and hemodynamic forces affect the
initiation and propagation of endocardial infection. By defining the mechanisms for these events, this research
will redefine our understanding of the key steps in the pathogenesis of streptococcal IE. These concepts and
findings will be broadly applicable to other endovascular pathogens, and will provide novel insights into
microbial interactions with host glycans.
项目摘要
口腔链球菌是感染性心内膜炎(IE)的主要原因。这些物种中有几个表达了siglec-
就像,富含丝氨酸的重复(SRR)粘附在人糖蛋白上结合多种O连接的唾液酸糖果和
细胞。 Gordonii M99链球菌的SRR粘附素GSPB的表达导致病毒增加
IE的动物模型。人们认为这种增强的致病性被认为是GSPB与
Trisacharide siAllyl-T抗原(STA,核心1 sialoglycan)在血小板受体GPIB上,导致增加
细菌在血流中的附着在心脏瓣膜表面和植被形成。等源性
M99的突变体表达GSPB变体,优先结合核心2 sialoglycans(例如,辅助乙酰乳糖胺)
与WT菌株相比,毒力较少。这些发现表明类型的差异
Sialoglycan绑定(“选择性”)会影响生物体启动和传播心内膜的能力
感染,一些相互作用增强了发病机理,而其他相互作用减少了疾病。我们
假设在体内,血液中链球菌在血小板或心脏表面上的结合
有助于引发感染,并且通过高剪切流产生的血液动力学作用增强了这种结合。
相反,与血细胞上的核心2唾液聚糖结合可能会导致细菌清除率增加,从而
衰减病毒。细菌在瓣膜上与核1与核心2唾液的瓣膜上的随后相互作用
通过对血小板激活,闭合或内皮愈合的不同影响,可能会影响疾病的进展。
为了进一步解决Sialoglycan结合选择性在IE发病机理中的作用,我们将通过流量进行比较
上述等源性菌株在体外与血小板,RBC和WBC结合。我们还将检查是否
这些菌株结合了gpib sialoglycan含量不同的血小板,以及与sta与core 2的结合
结构会影响血小板激活。此外,我们将评估选择性如何影响
通过微流体室建模的细菌损坏心脏表面
von Willebrand因子,胶原蛋白或活化的人血管内皮细胞以及血液动力学的作用
绑定的力。我们还将通过评估菌株来探索选择性对植被形成的影响
触发血小板收缩力以及对血小板依赖性内皮愈合的影响的差异。我们也会
比较这些菌株在体内产生的植被的关键特征与病毒相关的关键特征,包括共同特征
血小板和生物膜产生的定位。
这些研究将提供有关唾液酸聚会的选择性和血液动力学如何影响的新见解。
心内膜感染的启动和传播。通过定义这些事件的机制,这项研究
将重新定义我们对链球菌IE发病机理的关键步骤的理解。这些概念和
调查结果将广泛适用于其他血管内病原体,并将提供新颖的见解
与宿主聚糖的微生物相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Aron Lopez其他文献
Jose Aron Lopez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Aron Lopez', 18)}}的其他基金
Molecular and Translational Studies in Hematologic Disorders
血液疾病的分子和转化研究
- 批准号:
10379456 - 财政年份:2019
- 资助金额:
$ 80.67万 - 项目类别:
Molecular and Translational Studies in Hematologic Disorders
血液疾病的分子和转化研究
- 批准号:
10593910 - 财政年份:2019
- 资助金额:
$ 80.67万 - 项目类别:
Molecular and Translational Studies in Hematologic Disorders
血液疾病的分子和转化研究
- 批准号:
9894847 - 财政年份:2019
- 资助金额:
$ 80.67万 - 项目类别:
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations
冯维勒布兰德病突变的生物合成和功能后果
- 批准号:
8461835 - 财政年份:2013
- 资助金额:
$ 80.67万 - 项目类别:
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations
冯维勒布兰德病突变的生物合成和功能后果
- 批准号:
8604417 - 财政年份:2013
- 资助金额:
$ 80.67万 - 项目类别:
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations
冯维勒布兰德病突变的生物合成和功能后果
- 批准号:
9002893 - 财政年份:2013
- 资助金额:
$ 80.67万 - 项目类别:
von Willebrand Factor in Sickle Cell Disease Pathophysiology
镰状细胞病病理生理学中的冯维勒布兰德因子
- 批准号:
9312099 - 财政年份:2012
- 资助金额:
$ 80.67万 - 项目类别:
Regulation of von Willebrand Factor Reactivity
冯维勒布兰德因子反应性的调节
- 批准号:
8077284 - 财政年份:2009
- 资助金额:
$ 80.67万 - 项目类别:
Regulation of von Willebrand Factor Reactivity
冯维勒布兰德因子反应性的调节
- 批准号:
7585810 - 财政年份:2009
- 资助金额:
$ 80.67万 - 项目类别:
Regulation of von Willebrand Factor Reactivity
冯维勒布兰德因子反应性的调节
- 批准号:
8278424 - 财政年份:2009
- 资助金额:
$ 80.67万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:72202154
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 80.67万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 80.67万 - 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
- 批准号:
10785755 - 财政年份:2023
- 资助金额:
$ 80.67万 - 项目类别:
Investigating how bHLH circuits integrate signals for cell fate decisions
研究 bHLH 电路如何整合信号以决定细胞命运
- 批准号:
10722452 - 财政年份:2023
- 资助金额:
$ 80.67万 - 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 80.67万 - 项目类别: